Condition
Eczema Herpeticum
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed5
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03038932CompletedPrimary
Etiology of Eczema Herpeticum (EH)
NCT01494142Completed
Registry for the Atopic Dermatitis Research Network
NCT01429311Completed
Interferon Responses in Eczema Herpeticum
NCT00438022Completed
Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic Dermatitis
NCT00822276Completed
The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA)
Showing all 5 trials